Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.8039 +0.0439 (+5.78%)

Streaming Delayed Price Updated: 11:54 AM EDT, Jun 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Recap: Longeveron Q1 Earnings ↗

May 13, 2022

Longeveron (NASDAQ:LGVN) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 13, 2022 ↗

May 13, 2022

Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.

Via Benzinga

Longeveron's Earnings: A Preview ↗

May 12, 2022

Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that Longeveron will...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 12, 2022

With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it's for Thursday!

Via InvestorPlace

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Follow the Insiders and Buy the Dip in These 3 Stocks ↗

May 06, 2022

These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.

Via InvestorPlace

Analyzing Longeveron Inc. - common stock's Short Interest ↗

April 19, 2022

Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has risen 35.04% since its last report. The company recently reported that it has 746.20 thousand shares sold...

Via Benzinga

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

Longeveron Partners With US Department Of Veterans Affairs For Its Phase 2 Alzheimer's Trial ↗

April 18, 2022

Photo by Caleb Fisher on Unsplash

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 21, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...

Via Benzinga

Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027

April 13, 2022

Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent...

Via FinancialNewsMedia

EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial ↗

April 13, 2022

Longeveron Inc (NASDAQ: LGVN) has announced a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs (VA) to add Miami VA clinical site to its...

Via Benzinga

5 Short Squeeze Candidates To Watch: Aterian Tops The List, System1 Group And Longeveron Join Leaderboard ↗

April 11, 2022

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value...

Via Benzinga

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes ↗

April 06, 2022

Pre-open movers

Via Benzinga

5 Stocks To Watch For April 6, 2022 ↗

April 06, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.30 per share on revenue of $1.41 million before the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 05, 2022

Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 04, 2022

Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

April 04, 2022

Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (...

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 05, 2022

Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 04, 2022

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 01, 2022

Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 01, 2022

Good morning, investor! It's the last trading day of the week and that means it's time to get into the pre-market stock movers for Friday!

Via InvestorPlace

21 Stocks Moving in Friday's Pre-Market Session ↗

April 01, 2022

Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results. Chicken Soup for the Soul...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 01, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 180 Points; Creative Medical Technology Shares Spike Higher ↗

March 31, 2022

U.S. stocks traded lower toward the end of trading following the release of weekly jobless claims data. The Dow traded down 0.52% to 35,043.99 while the NASDAQ fell 0.22% to 14,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 31, 2022

Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

March 31, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.